Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
222.15
+4.77 (2.19%)
At close: Feb 6, 2026, 4:00 PM EST
224.00
+1.85 (0.83%)
After-hours: Feb 6, 2026, 7:11 PM EST
Ascendis Pharma Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$268.19
Upside
+20.72%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $246 → $260 | Strong Buy | Maintains | $246 → $260 | +17.04% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $342 | Buy | Initiates | $342 | +53.95% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $245 → $250 | Buy | Maintains | $245 → $250 | +12.54% | Jan 20, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $322 → $330 | Buy | Maintains | $322 → $330 | +48.55% | Jan 20, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $297 → $322 | Buy | Maintains | $297 → $322 | +44.95% | Jan 9, 2026 |
| TD Cowen | TD Cowen | Strong Buy Reiterates $325 | Strong Buy | Reiterates | $325 | +46.30% | Jan 7, 2026 |
| Stifel | Stifel | Strong Buy Maintains $254 → $256 | Strong Buy | Maintains | $254 → $256 | +15.24% | Dec 11, 2025 |
| Wedbush | Wedbush | Buy Reiterates $220 | Buy | Reiterates | $220 | -0.97% | Nov 18, 2025 |
| Raymond James | Raymond James | Strong Buy Initiates $271 | Strong Buy | Initiates | $271 | +21.99% | Oct 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $203 → $254 | Buy | Maintains | $203 → $254 | +14.34% | Oct 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $260 → $264 | Buy | Maintains | $260 → $264 | +18.84% | Oct 9, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $227 → $230 | Strong Buy | Maintains | $227 → $230 | +3.53% | Sep 2, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $254 → $260 | Buy | Maintains | $254 → $260 | +17.04% | Aug 19, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $243 → $290 | Strong Buy | Maintains | $243 → $290 | +30.54% | Aug 8, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $210 → $230 | Buy | Maintains | $210 → $230 | +3.53% | Aug 8, 2025 |
| Wedbush | Wedbush | Buy Maintains $212 → $220 | Buy | Maintains | $212 → $220 | -0.97% | Aug 8, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.